𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma

✍ Scribed by Jagavkar, RS ;Shakespeare, TP ;Stevens, MJ


Book ID
108931885
Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
489 KB
Volume
42
Category
Article
ISSN
0004-8461

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The incidence of subsequent endometrial
✍ Katsuyoshi Katase; Yuko Sugiyama; Katsuhiko Hasumi; Masataka Yoshimoto; Fujio Ka πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

## Background: Tamoxifen commonly is used as adjuvant therapy for all stages of breast carcinoma. however, several studies have suggested an association between the use of tamoxifen in breast carcinoma patients and the subsequent development of endometrial carcinoma. the objective of this study was

Cost-effectiveness of switching to exeme
✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to

A randomized trial of long term adjuvant
✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w